An active tryptophan metabolite and synthetic intermediate increases colonic production of IL-22 and restores colonization resistance to C. albicans infection in a wild-type but not Ahr-/- mouse model of mucosal candidiasis at 18 mg/kg reduces intestinal mucosal damage in a mouse model of DSS-induced colitis